Measuring Oxygenation Change in Individual Tumors
Author Information
Author(s): RV Iyer, E Kim, RF Schneider, JD Chapman
Primary Institution: Fox Chase Cancer Center
Hypothesis
The bioreducible hypoxic marker technique can quantify oxygenation changes within individual tumors.
Conclusion
The dual hypoxic marker technique effectively measures oxygenation changes in individual rodent tumors, indicating significant fluctuations in hypoxic fractions.
Supporting Evidence
- Fluctuating hypoxia can account for at least 25% of the total hypoxic fraction in some tumors.
- Reductions in T/B ratios were observed in all tumors after treatment with nicotinamide and carbogen.
- Changes in T/B ratios of 8-25% were observed in 36% of tumors.
Takeaway
This study shows a new way to see how much oxygen is in tumors, which helps understand how they respond to treatments.
Methodology
The study used two radiolabelled hypoxic markers to measure tumor-blood ratios in mice and rats, assessing changes in oxygenation after treatment with nicotinamide and carbogen.
Potential Biases
Potential bias in marker uptake due to varying tumor characteristics and treatment responses.
Limitations
The study primarily involved rodent models, which may not fully represent human tumor behavior.
Participant Demographics
Rodent models including EMT-6 tumor-bearing scid mice and Dunning rat prostate carcinomas.
Statistical Information
P-Value
p<0.0001
Statistical Significance
p<0.0001
Want to read the original?
Access the complete publication on the publisher's website